Ontology highlight
ABSTRACT: Background
PH domain and leucine-rich repeat protein phosphatase 2 (PHLPP2) has been reported to be a potent tumor suppressor in many human cancers. However, PHLPP2 has not been fully researched as a putative clinical prognostic biomarker of lung cancer.Methods
The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases including data on 1383 non-small cell lung cancer (NSCLC) patients were used to determine PHLPP2 expression. PHLPP2 expression was then examined by immunohistochemistry, and its clinical significance analyzed in 134 NSCLC patients, including 73 patients with adenocarcinoma and 81 with squamous cell carcinoma.Results
We found PHLPP2 expression to be less pronounced in NSCLC tissue samples than that in nontumoral lung tissues according t
SUBMITTER: Wang H
PROVIDER: S-EPMC6825916 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature